Diabetes is a chronic condition characterised by insufficient insulin secretion and hyperglycemia as a result. Microvascular and macrovascular disease are two types of diabetic complications that are affected by good diabetes management. Many diabetics rely on subcutaneous insulin injections or continuous infusions to keep their blood sugar levels under control. Insulin delivery via new routes Since the 1920s, subcutaneous insulin has been used to treat diabetes; nevertheless, despite a variety of formulations, intensive insulin therapy including many daily injections has not acquired universal clinical approval. The search for a successful, well-tolerated nonenteral method for delivering insulin began in the 1920s, and has included ocular, buccal, rectal, vaginal, and other routes. Given that insulin injection therapy is burdensome for many patients, novel insulin administration routes are of interest in the diabetes sector. The use of inhalation to administer insulin to the lungs will be discussed in this review. Inhaled insulin's safety as well as efficacy in contrast to subcutaneous insulin in diverse diabetic populations are discussed. Until recently, many researchers considered that noninvasively given insulin had too low a bioavailability to be useful in clinical practise. Inhaled insulin, on the other hand, appears to be an effective, well-tolerated, and noninvasive alternative to subcutaneous regular insulin, according to a growing body of research. Importantly, inhaled insulin has a more physiological insulin profile than injectable insulin.
Cite this article:
Komal. P. Kumbhar, S.S. Suryawanshi, Sachinkumar. V. Patil. Novel Route of Inhaled Insulin for Diabetes Treatment. Asian Journal of Pharmacy and Technology. 2022; 12(1):25-2. doi: 10.52711/2231-5713.2022.00005
Komal. P. Kumbhar, S.S. Suryawanshi, Sachinkumar. V. Patil. Novel Route of Inhaled Insulin for Diabetes Treatment. Asian Journal of Pharmacy and Technology. 2022; 12(1):25-2. doi: 10.52711/2231-5713.2022.00005 Available on: https://ajptonline.com/AbstractView.aspx?PID=2022-12-1-5
1. Gaurav Tiwari,
Ruchi Tiwari, Birendra Srivastava, L. Bhati, P. Pandey, Saurabh. K. Bannerjee. International
Journal of Pharmaceutical Investigation, 2012 March; Page No:2-11
2. R.R. Bhagwat
And I.S. Vaidhya. International Journal of Pharmaceutical Sciences and Research,
01 March 2013; Page No: 970-982
3. Lucy. D.
Mastrandrea. An Article of Inhaled Insulin for Diabetes, 2010 March; Page No:47-58
mahadev /mechanism of action of insulin
and Danial.E. Baker, FASHP. A Article of Diabetes Spectrum,2009 March; Page No:2-6
saragi /insulin through inhalation
9. Cefalu Wt,
Skyler Js, Kourides IA, Et Al. Inhaled Human Insulin Treatment in Patient with Type
2 Diabetes Mellitus,2001; Page No:203-207
10. Rosen stock
J, Zinman B, Murphy LJ, Et Al. Inhaled Insulin improves Glycemic Control ,2005;
Page No: 549 -558
11. Wolff RK.
Safety Of Inhaled Protein for Therapeutic Use,2014 Nov; Page No:197-219
T, Belanger A, Bohannon NJV, Schwantz Sl. Efficacy and Safety of Inhaled Insulin.
2004; Page No :2622-2627
13. Cramer JA,
Okikawa J, Bellair S, Clauson P. Compliance with Inhaled Insulin ,2004; Page No:
14. Black .C,
Cummins E, Royle. Philip. S, Wagh. N. The Clinical Effectiveness and Cost Effectiveness
of Inhaled Insulin,2007; Page No: 1- 26
15. Peggy Soule
Odegurd. A Journal If Exubera Inhaled Insulin, 2005 march; Page No 843-853
Henry Et Al. A Journal of Diabetes Care, 2003 March; Page No: 1-4
17. Julio Rosenstock,
Douglas Muchmore, Diana Swanson, Jennifer Schmitke. Expert Review of Medical Devices.
2007; Page No 683-692
18. Robert Angelo,
Kathleen Rouseau, Peter Richardson. A Journal of Diabetes Science and Technology.
2009 May; Page No: 545-554
Klonoff. A Journal of Diabetes Science and Technology. 2014 Nov; Page No:1071-1073